Anthem Blue Cross (HMO, PPO, EPO)
Danyelza (naxitamab-gqgk)
Drugs for Cancer : Drugs for Cancer
  • Cryopyrin-Associated Periodic Syndromes (CAPS):
    Age Requirement: >= 12
    Duration: 1 year(s)
    Documented Diagnosis: No
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified

    Recurrent Pericarditis :
    Age Requirement: >= 12
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified

  • Quantity Limit: limit maximum 20 EA PER 30 day(s)
  • Quantity Limit: 1 tablet per 1 day(s).
  • Prior Authorization: PA_APPLIES